- Home
- CMPS vs UHG Comparison
CMPS vs UHG Comparison
Compare CMPS & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- UHG
- Stock Information
- Founded
- CMPS 2020
- UHG 2004
- Country
- CMPS United Kingdom
- UHG United States
- Employees
- CMPS N/A
- UHG 196
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- UHG Homebuilding
- Sector
- CMPS Health Care
- UHG Consumer Discretionary
- Exchange
- CMPS Nasdaq
- UHG Nasdaq
- Market Cap
- CMPS 280.2M
- UHG 253.1M
- IPO Year
- CMPS 2020
- UHG N/A
- Fundamental
- Price
- CMPS $4.03
- UHG $4.32
- Analyst Decision
- CMPS Strong Buy
- UHG
- Analyst Count
- CMPS 6
- UHG 0
- Target Price
- CMPS $33.60
- UHG N/A
- AVG Volume (30 Days)
- CMPS 666.3K
- UHG 82.5K
- Earning Date
- CMPS 10-31-2024
- UHG 11-08-2024
- Dividend Yield
- CMPS N/A
- UHG N/A
- EPS Growth
- CMPS N/A
- UHG N/A
- EPS
- CMPS N/A
- UHG N/A
- Revenue
- CMPS N/A
- UHG $445,729,916.00
- Revenue This Year
- CMPS N/A
- UHG N/A
- Revenue Next Year
- CMPS N/A
- UHG N/A
- P/E Ratio
- CMPS N/A
- UHG N/A
- Revenue Growth
- CMPS N/A
- UHG 6.19
- 52 Week Low
- CMPS $3.86
- UHG $4.01
- 52 Week High
- CMPS $12.75
- UHG $9.48
- Technical
- Relative Strength Index (RSI)
- CMPS 37.75
- UHG 36.00
- Support Level
- CMPS $3.86
- UHG $4.01
- Resistance Level
- CMPS $4.20
- UHG $4.76
- Average True Range (ATR)
- CMPS 0.29
- UHG 0.35
- MACD
- CMPS 0.00
- UHG -0.05
- Stochastic Oscillator
- CMPS 16.59
- UHG 14.29
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments.